oncology

AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
Mon, 03/11/19 - 10:13 pm
AstraZeneca
oncology
microbiome
Seres Therapeutics
Private oncology outfit Oncternal uses GTx as shell to make Nasdaq debut
Endpoints
Thu, 03/7/19 - 10:27 am
Oncternal
GTx
NASDAQ
oncology
Gilead oncology chief departing to head up Glenmark spin-out
Biopharma Dive
Wed, 03/6/19 - 12:37 am
oncology
Alessandro Riva
Gilead Sciences
Glenmark
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report
Fierce Pharma
Wed, 02/20/19 - 11:59 am
M&A
oncology
neurology
Rare Diseases
Pfizer
Merck
JNJ
Biogen
Biomarin
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
oncology
Roche
AbbVie
AstraZeneca
Sanofi’s latest R&D remodeling spotlights what’s hot (bispecifics) and what’s not (CTLA-4) in oncology today
Endpoints
Fri, 02/8/19 - 09:30 am
Sanofi
oncology
Oncology round-up: CAR-T conference raises hopes for solid tumour therapy
Pharmaforum
Fri, 02/1/19 - 10:44 pm
CAR-T
CAR-T Congress
oncology
Novartis
Kymriah
Europe
Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019
BioSpace
Mon, 01/28/19 - 10:44 pm
Pfizer
oncology
cancer
A two-fisted punch against cancer metastasis
Fierce Biotech
Sat, 01/26/19 - 11:47 am
cancer
MMP inhibitors
Duke University
oncology
GSK closes acquisition of Tesaro for $5.1bn
Pharmaceutical Business Review
Wed, 01/23/19 - 10:39 am
GSK
Tesaro
M&A
oncology
ADC doses first patient in phase I trial of ADCT-601 in advanced solid tumors
Pharmaceutical Business Review
Fri, 01/18/19 - 09:12 pm
ADC Therapeutics
oncology
ADCT-601
solid tumors
clinical trials
AstraZeneca rejigs commercial ranks around cancer, biopharma in wake of Mallon's departure
Fierce Pharma
Tue, 01/8/19 - 09:18 am
AstraZeneca
reorganization
oncology
restructuring
Pfizer, Merck shares smoking hot in 2018 despite doldrums for overall biopharma sector
Fierce Pharma
Thu, 01/3/19 - 09:46 am
oncology
Merck
Pfizer
Novartis oncology CEO quits after less than a year
Pharmaforum
Thu, 12/20/18 - 10:07 am
Novartis
oncology
Susanne Schaffert
Liz Barrett
Auron and Elucidata Launch AI Driven Collaboration to Identify Targets for Differentiation-Based Oncology Therapies
CP WIre
Wed, 12/19/18 - 10:09 am
artificial intelligence
Auron Therapeutics
Elucidata
oncology
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Wed, 12/12/18 - 06:41 pm
Merck
Roche
solid tumors
oncology
biomarkers
companion diagnostics
diagnostics
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
BioSpace
Wed, 12/12/18 - 12:19 am
Amgen
clinical trials
diversity
minorities
oncology
Pfizer to add 100 oncology R&D jobs, cut others amid restructure
Biopharma Dive
Wed, 12/12/18 - 12:09 am
Pfizer
layoffs
hirings
R&D
oncology
FDA Drafts Guidance on Oncology Companion Diagnostics
RAPS.org
Sun, 12/9/18 - 03:39 pm
FDA
cancer companion diagnostics
oncology
All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division
Endpoints
Mon, 12/3/18 - 12:10 pm
Novartis
oncology
FF-10158
radiopharmaceuticals
Fujifilm Toyama
Advanced Accelerator Application

Pages